globalpatients-admin

GP0582B CIDP Study in US and UK

At Global Patients we are looking for adult patients with CIDP who are stable on intravenous treatment (IVIG) as well as caregivers for such patients to take part on a 60-minute telephone interview. We are looking to better understand the experiences of people living with this condition.  This research is in the US and in the UK. The study does not include any medication in-take. Eligible patients would receive 150

GP0301D mHSPC & nmCRPC patients study in the US

Global Patients is collaborating on a research study to better understand the experience of patients with prostate cancer who have received an androgen receptor inhibitor (ARI) as a form of treatment. The research study is being conducted with IQVIATM, a healthcare research firm (www.iqvia.com), and a pharmaceutical company that is working on developing therapies for patients with prostate cancer.We are seeking adult patients who have been diagnosed with prostate cancer,

GP0719A mCRPC and mHSPC patients in France

We have a new study in France please see specifications below Dans Global Patients nous réalisons une étude et nous souhaiterions connaître vos opinions et expériences concernant certains traitements médicaux pour le cancer de la prostate. Les informations seront utilisées afin de recueillir des idées quant à de futures options thérapeutiques. L’étude se compose de quatre tâches de 15 minutes et les participants reçoivent 130 euros à la fin de

GP0261D Caregivers of mild to moderate dementia with apathy US

Hi everyone! We are conducting a study with caregivers of patients with dementia-related apathy in the United States. The study consists of a 60-minute phone interview and a 90 minute follow up interview. To show our appreciation for your time, you will be compensated with $125 for the first interview and $175 for the second interview , plus $25 for sending the required confirmation of diagnosis.If you would like to

GP0349A CML CANADA

Global Patients has launched a new study for CML patients in Canada, see specifications below Global Patients est actuellement à la recherche d’adultes âgés d’au moins 18 ans ayant reçu un diagnostic de leucémie myéloïde chronique (LMC) et disposés à participer à une étude par sondage rémunérée au Canada.  Le but du sondage est d’en apprendre davantage sur l’expérience des patients atteints de leucémie myéloïde chronique (LMC) en ce qui concerne

GP0740B ESRD patients US

Have you been diagnosed with End-Stage Renal Disease (ESRD) and are on the waiting list for a kidney transplant or have you had a kidney transplant in the past 3 years (or have active or at high risk of Antibody Mediated Rejection (AMR) and are you aged 18 years or older? If so, you may be eligible to participate in an interview study that is being conducted on behalf of

GP0349A CML patients US CAN

Global Patients is currently looking for adults aged 18 years or older living in the US, diagnosed with chronic myeloid leukemia (CML) to participate in an upcoming paid survey study. The purpose of this survey is to learn about the experiences of CML patients and how their diagnosis impacts their life quality, their opinion on their communication with their health care providers and understand more about their point of view on

GP0146A Breast Cancer FR

At Global Patients we have launched a new study in France, please see details below; Global Patients recherche actuellement des femmes âgées de 18 ans et plus, chez qui on a diagnostiqué un cancer du sein à récepteurs hormonaux positifs HR+ (c.-à-d., à récepteur des œstrogènes positif ou ER+)/HER2 négatif, pour participer à une prochaine étude par entretien rémunéré. Cette étude a pour objectif d’en apprendre davantage sur votre vécu avec

GP0146A Breast Cancer in Canada

At Global Patients we are looking for women diagnosed  with Hormone Receptor positive (HR+) (i.e.,Estrogen Receptor-Positive, ER+)/HER2 negative breast cancer in Canada to participate in an upcoming paid interview study. Study participants, who will agree to provide evidence of diagnosis, will be invited to attend a 90-minute telephone interview. There is no medical treatment being provided as part of this study and all participants will be remunerated with 310 CAD

GP0324D Geographic Atrophy study in the US

We are running a research study to explore patients’ experiences with Geographic Atrophy (GA) in the US. You would participate in a telephone interview if you have been diagnosed with GA to better understand your experiences with these conditions. Qualified participants will receive a $185 electronic gift card after completion of the phone interview. This value is based on an approximate time commitment of 2 hours and 30 minutes to

GP0364D PBC in the US and Canada

We are conducting a study on behalf of IQVIA. We want to know about patients aged 18 – 65 who have been diagnosed with primary biliary cholangitis (PBC) by their physician in the US and Canada. The research will involve participating in a telephone interview. To participate in this study, you will also need access to a computer / tablet and a stable internet connection. The interview will last about

GP0146A Breast Cancer US

Global Patients is currently looking for women 18 years old and over, diagnosed with Hormone Receptor positive HR+ (i.e., Estrogen Receptor-Positive, ER+)/HER2 negative breast cancer to participate in an upcoming paid interview study. The purpose of this study is to learn about your experience with HR+ (i.e., ER+)/HER2 negative breast cancer including disease symptoms and treatment side-effects, and their impact on your quality of life, activities of daily living, and

GP0287C mCRC patients and caregivers in France

At Global Patients we have launched a new study in France, see information below:
chez Global Patients, nous sommes en train de lancer une nouvelle étude en France dans laquelle nous souhaitons recueillir des informations de patients qui souffrent cancer colorectal métastatique et de leurs soignants.

GP0195D Metastatic Colorectal Cancer US

IQVIATM, a worldwide healthcare consulting firm, is currently conducting a research study, to better understand the experience of patients treated for metastatic colorectal cancer (i.e., where the cancer has spread to other parts of the body).
Global Patients would like to invite you to participate in this study, which includes a 90-minute, one-on-one telephone interview with one of our senior healthcare researchers. The interview will focus on patient experience with metastatic colorectal cancer, especially signs, symptoms and impacts. The interview will occur at a time convenient for you.

GP0009D Osteoporosis in the US

At Global Patients we are launching a new study where we want to learn about what it is like to have Osteoporosis . It would consist of a 60-minute phone interview and participants will be rewarded with $75  in the form of a virtual visa card in appreciation for their time. Your participation is entirely voluntarily, and your personal information will be kept confidential. We comply with all relevant laws